Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEDAM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,703
Award facts
- Contract value 100% obligated
- $44,702.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,702.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This non-competitive, non-set-aside delivery order represents a purchase of the biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and other allergic conditions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is issued as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA.
This delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle enables the contractor to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The firm fixed pricing structure and competitive track record position AmerisourceBergen as a critical vendor within the federal medical procurement supply chain.
Quick answers
Who was awarded contract SPE2DB25FEDAM?
SPE2DB25FEDAM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FEDAM worth?
The government has obligated $44,703 on SPE2DB25FEDAM.
Is contract SPE2DB25FEDAM an order under another contract?
Yes. SPE2DB25FEDAM is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEDAM competed?
The extent of competition for SPE2DB25FEDAM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award